$4.02
0.010.25%
最終更新: Oct 23, 6:37 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 24
Benzinga
© 2026 Benzinga | All Rights Reserved
Quoin Pharmaceuticals (QNRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.78 | $-2.17 | $-4.98 | $-3.70 |
| Actual | $-1.90 | $-1.77 | $-1.74 | $-6.71 |
| Surprise | -6.74% | +18.4% | +65.1% | -81.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.78 | $-1.83 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-1.90 | $-1.78 | -6.74 % |
| Q1 | May 7, 2026 | $-1.77 | $-2.17 | 18.4 % |
| Q4 | Mar 26, 2026 | $-1.74 | $-4.98 | 65.1 % |
| Q3 | Nov 6, 2025 | $-6.71 | $-3.70 | -81.3 % |